Gisela Pogátsa-Murray

Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel

Nicolas von Beckerath, Dirk Taubert, Gisela Pogátsa-Murray et al. · Circulation · 2005 · 626 citations · Full text

Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary Syndromes

Franz‐Josef Neumann, Adnan Kastrati, Gisela Pogátsa-Murray et al. · JAMA · 2003 · 462 citations

Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis

Meinrad Gawaz, Korbinian Brand, Timm Dickfeld et al. · Atherosclerosis · 2000 · 253 citations

Inflammation, Thrombosis, Interleukin-1-dependent Mechanism +15

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days

Nicolas von Beckerath, Adnan Kastrati, Anna Wieczorek et al. · European Heart Journal · 2007 · 204 citations · Full text

Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy

Adnan Kastrati, Nicolas von Beckerath, Alexander Joost et al. · Circulation · 2004 · 195 citations · Full text